Cspc Pharmaceutical Group Stock Today
| CHJTF Stock | USD 0.67 0.16 19.28% |
Performance3 of 100
| Odds Of DistressLess than 10
|
CSPC Pharmaceutical is trading at 0.67 as of the 24th of November 2024. This is a 19.28 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.67. CSPC Pharmaceutical has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for CSPC Pharmaceutical Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of August 2023 and ending today, the 24th of November 2024. Click here to learn more.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. The company has 11.93 B outstanding shares. More on CSPC Pharmaceutical Group
Moving against CSPC Pink Sheet
CSPC Pink Sheet Highlights
| Chairman | Dongchen Cai |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
CSPC Pharmaceutical Group [CHJTF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 13.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSPC Pharmaceutical's market, we take the total number of its shares issued and multiply it by CSPC Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CSPC Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 11.93 B outstanding shares.
CSPC Pharmaceutical Group has accumulated about 13.97 B in cash with 4.64 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.17, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check CSPC Pharmaceutical Probability Of Bankruptcy
Ownership AllocationCSPC Pharmaceutical holds a total of 11.93 Billion outstanding shares. CSPC Pharmaceutical Group retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CSPC Ownership Details
CSPC Pharmaceutical Risk Profiles
| Mean Deviation | 2.2 | |||
| Semi Deviation | 3.65 | |||
| Standard Deviation | 7.84 | |||
| Variance | 61.4 |
CSPC Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in CSPC Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
CSPC Pharmaceutical Corporate Directors
| Qingxi Wang | Executive Director | Profile | |
| Kin Chak | Executive Director | Profile | |
| Weidong Pan | Chief Accountant, Executive Director and Director of Shijiazhuang Pharmaceutical Group Company Limite | Profile | |
| Huaiyu Wang | Executive Director | Profile |
Other Information on Investing in CSPC Pink Sheet
CSPC Pharmaceutical financial ratios help investors to determine whether CSPC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Pharmaceutical security.